Published in
American Society for Pharmacology and Experimental Therapeutics (ASPET), Molecular Pharmacology, 5(89), p. 593-605, 2016
Links
Tools
Fevipiprant (QAW039) a slowly dissociating CRTh2 antagonist with the potential for improved clinical efficacy.
Journal article published in 2016 by
David A. Sykes,
Michelle E. Bradley,
Darren M. Riddy 
,
Elizabeth Willard,
John Reilly,
Asadh Miah,
Carsten Bauer,
Simon J. Watson,
David A. Sandham,
Gerald Dubois,
Steven J. Charlton
,
Elizabeth Willard,
John Reilly,
Asadh Miah,
Carsten Bauer,
Simon J. Watson,
David A. Sandham,
Gerald Dubois,
Steven J. Charlton
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 